Abstract:Nucleoside phosphorylases (NPs) are pivotal enzymes in the salvage pathway, catalyzing the reversible phosphorolysis of nucleosides to produce nucleobases and α-D-ribose 1-phosphate. Due to their efficiency in catalyzing nucleoside synthesis from purine or pyrimidine bases, these enzymes hold significant industrial importance in the production of nucleoside-based drugs. Given that the thermodynamic equilibrium for purine NPs (PNPs) is favorable for nucleoside synthesis-unlike pyrimidine NPs (PyNPs, UP, and TP)-multi-enzymatic systems combining PNPs with PyNPs, UPs, or TPs are commonly employed in the synthesis of nucleoside analogs. In this study, we report the first development of two engineered bifunctional fusion enzymes, created through the genetic fusion of purine nucleoside phosphorylase I (PNP I) and thymidine phosphorylase (TP) from Thermus thermophilus. These fusion constructs, PNP I/TP-His and TP/PNP I-His, provide an innovative one-pot, single-step alternative to traditional multi-enzymatic synthesis approaches. Interestingly, both fusion enzymes retain phosphorolytic activity for both purine and pyrimidine nucleosides, demonstrating significant activity at elevated temperatures (60-90 °C) and within a pH range of 6-8. Additionally, both enzymes exhibit high thermal stability, maintaining approximately 80-100% of their activity when incubated at 60-80 °C over extended periods. Furthermore, the transglycosylation capabilities of the fusion enzymes were explored, demonstrating successful catalysis between purine (2'-deoxy)ribonucleosides and pyrimidine bases, and vice versa. To optimize reaction conditions, the effects of pH and temperature on transglycosylation activity were systematically examined. Finally, as a proof of concept, these fusion enzymes were successfully employed in the synthesis of various purine and pyrimidine ribonucleoside and 2'-deoxyribonucleoside analogs, underscoring their potential as versatile biocatalysts in nucleoside-based drug synthesis.

A selective and atom-economic rearrangement of uridine by cascade biocatalysis for production of pseudouridine

A deamination-driven biocatalytic cascade for the synthesis of ribose-1-phosphate

[Whole-cell catalytic production of pseudouridine by recombinant Escherichia coli]

Cloning and Characterization of Purine Nucleoside Phosphorylase in Escherichia Coli and Subsequent Ribavirin Biosynthesis Using Immobilized Recombinant Cells

Systematic Engineering of Escherichia coli for Efficient Production of Pseudouridine from Glucose and Uracil

Efficient Synthetic Access to Stable Isotope Labelled Pseudouridine Phosphoramidites for RNA NMR Spectroscopy

EFFICIENT PRODUCTION OF URIDINE 5′-DIPHOSPHO-N-ACETYLGLUCOSAMINE BY THE COMBINATION OF THREE RECOMBINANT ENZYMES AND YEAST CELLS

Metabolic Engineering of Escherichia coli for Efficient Production of Pseudouridine

Biocatalytic nucleobase diversification of 4’-thionucleosides and de novo RNA synthesis using 5-ethynyl-4’-thiouridine

Enzymatic Synthesis of 2′-Deoxyuridine by Whole Cell Catalyst Co-Expressing Uridine Phosphorylase and Thymidine Phosphorylase Through Auto-Induction System

Improving the fidelity of uridine analog incorporation during in vitro transcription

Biocatalytic Synthesis of Ribonucleoside Analogues Using Nucleoside Transglycosylase-2

Biocatalytic Nucleobase Diversification of 4'‐Thionucleosides and Application of Derived 5‐Ethynyl‐4'‐thiouridine for RNA synthesis detection

5‐Ethynyluridine: a bio‐orthogonal uridine variant for mRNA‐based therapies and vaccines

2’,3’-protected nucleotides as building blocks for enzymatic de novo RNA synthesis

Palladium‐Catalyzed C–H Olefination for Nucleic Acid Production

Efficient Chemoenzymatic Synthesis of Uridine 5'-Diphosphate N-acetylglucosamine and Uridine 5'-Diphosphate N-trifluoacetyl Glucosamine with Three Recombinant Enzymes.

2',3'‐protected nucleotides as building blocks for enzymatic de novo RNA synthesis

Engineering a Bifunctional Fusion Purine/Pyrimidine Nucleoside Phosphorylase for the Production of Nucleoside Analogs

Developing the E. Coli Platform for Efficient Production of UMP-derived Chemicals